Enivornmental factors and genetics play a role in colon health, but there may be another unexpected factor, as well.

VIBRANT (NCT06164704) was a Phase 2 global, randomized, double-blind, placebo-controlled, parallel group clinical trial that evaluated the efficacy and safety of verekitug over 24 weeks in 81 adults ...

A randomized placebo-controlled Finnish study showed that aspirin therapy does not provide significant relief for people ...

Receiving the novel monoclonal antibody stapokibart for 24 weeks lowered polyp size and nasal symptom severity vs. placebo in ...

In recent years, studies have taken a closer look at whether certain lifestyle choices might up your risk for colon cancer.

Detailed price information for Upstream Bio Inc (UPB-Q) from The Globe and Mail including charting and trades.

Upstream Bio's Phase 2 trial of verekitug in chronic rhinosinusitis met all endpoints, showing reduced nasal polyps, ...

A randomized placebo-controlled Finnish study showed that aspirin therapy does not provide significant relief for people ...

As colorectal cancer diagnoses surge among those under 55, Laura Johnston's candid podcast discussion breaks down why "dying ...